Company ExpreS2ion Biotech Holding AB Nasdaq Stockholm
Equities
SE0008348262
Pharmaceuticals
Business Summary
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Vaccines
100.0
%
| 14 | 100.0 % | 6 | 100.0 % | -55.21% |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Other Countries
88.6
%
| 8 | 67.2 % | 5 | 88.6 % | -45.21% |
Nordics
11.4
%
| 4 | 32.8 % | 1 | 11.4 % | -85.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bent Frandsen
CEO | Chief Executive Officer | - | 31/12/15 |
Keith Alexander
DFI | Director of Finance/CFO | 48 | 30/09/20 |
Max M. Søgaard
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/12 |
Chief Tech/Sci/R&D Officer | 70 | 15/01/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jakob Knudsen
BRD | Director/Board Member | 56 | 31/03/17 |
Karin Garre
BRD | Director/Board Member | 67 | 25/05/21 |
Martin Jensen
FOU | Founder | 64 | 31/12/09 |
Sara Sande
BRD | Director/Board Member | 49 | 25/05/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,404,958 | 51,404,958 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Expres2ion Biotech Holding AB
SCION-DTU Science Park Agern Allé 1
2970, Hørsholm
+45 22 22 10 19
http://www.expres2ionbio.comSector
Sales per region
1st Jan change | Capi. | |
---|---|---|
-1.57% | 89.37B | |
+2.76% | 40.65B | |
-12.32% | 32.81B | |
+52.41% | 25B | |
-17.39% | 15.29B | |
-42.45% | 11.61B | |
-10.48% | 11.49B | |
+6.14% | 8.98B | |
-7.72% | 8.23B |